Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpoints.

Abbott, Iain J; Mouton, Johan W; Peleg, Anton Y; Meletiadis, Joseph

Abbott, Iain J; Mouton, Johan W; Peleg, Anton Y; Meletiadis, Joseph.

Afiliación

Abbott IJ; Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Mouton JW; Department of Medical Microbiology and Infectious Diseases, Research and Development Unit, Erasmus Medical Centre, Rotterdam, The Netherlands.
Peleg AY; Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Meletiadis J; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia.

J Antimicrob Chemother ; 76(12): 3201-3211, 2021 11 12.

Article en En | MEDLINE | ID: mdl-34473271

Asunto(s)

Fosfomicina; Infecciones Urinarias; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Enterococcus; Escherichia coli; Fosfomicina/farmacología; Humanos; Pruebas de Sensibilidad Microbiana; Pseudomonas aeruginosa; Vejiga Urinaria; Infecciones Urinarias/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Urinarias / Fosfomicina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google